Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
October 10, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Global Infectious Disease In Vitro Diagnostics Market Report (2022 to 2030) - High Demand for PoC Facilities is Driving Growth
October 05, 2022 05:38 ET
|
Research and Markets
Dublin, Oct. 05, 2022 (GLOBE NEWSWIRE) -- The "Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents), by Application (HPV, HIV),...
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
October 04, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Pharma Microbiology Testing Kits Global Market Report 2022: Popularity of Outsourcing Microbiology Testing Fuels Growth
September 29, 2022 08:08 ET
|
Research and Markets
Dublin, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The "Pharma Microbiology Testing Kits Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. The global pharma...
Global Clinical Microbiology Instruments and Reagents Market to Reach $5.8 Billion by 2026
September 28, 2022 07:38 ET
|
Research and Markets
Dublin, Sept. 28, 2022 (GLOBE NEWSWIRE) -- The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's...
Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management Adopts Limited Duration Stockholder Rights Plan LOWELL, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro...
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports second quarter 2022 commercial revenue of $3.9 million Lowers full year 2022 commercial revenue guidance to at least $17.0 million Implements organizational restructuring plan to right-size...
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
August 09, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
India In Vitro Diagnostics (IVD) Market Research Report 2022: Incidence of Disease, Life Expectancy, Population Demographics, Economic Status, Healthcare Utilization
July 22, 2022 04:38 ET
|
Research and Markets
Dublin, July 22, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics (IVD) in India" report has been added to ResearchAndMarkets.com's offering. This new report is designed to provide an overview of...
Middle East and Africa In-Vitro Diagnostics (IVD) Markets, 2021-2022 & 2026
July 20, 2022 04:38 ET
|
Research and Markets
Dublin, July 20, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics (IVD) in the Middle East and Africa" report has been added to ResearchAndMarkets.com's offering. There has been an increasing...